Immunomonitoring et thérapie cellulaire : l’exemple des patients traités par cellules stromales mésenchymateuses

Ménard, 2011, Immunosuppression et cellules souches mésenchymateuses - Mieux comprendre une propriété thérapeutique majeure, médecine/sciences, 27, 269, 10.1051/medsci/2011273269

Lee, 2009, Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6, Cell Stem Cell, 5, 54, 10.1016/j.stem.2009.05.003

Ortiz, 2003, Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects, Proc Natl Acad Sci U S A, 100, 840711, 10.1073/pnas.1432929100

Wu, 2008, Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats, Cell Transplant, 16, 993, 10.3727/000000007783472435

Ringdén, 2007, Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon, Leukemia, 21, 2271, 10.1038/sj.leu.2404833

Ringdén, 2006, Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease, Transplantation, 81, 1390, 10.1097/01.tp.0000214462.63943.14

Perico, 2011, Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility, Clin J Am Soc Nephrol CJASN, 6, 412, 10.2215/CJN.04950610

Chinnadurai, 2013, From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases, BioMed Res Int, 2013, 929842, 10.1155/2013/929842

Hedhli, 2017, Multimodal Assessment of Mesenchymal Stem Cell Therapy for Diabetic Vascular Complications, Theranostics, 7, 3876, 10.7150/thno.19547

Haab, 2005, Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data, Proteomics, 5, 3278, 10.1002/pmic.200401276

Caliari-Oliveira, 2016, Xenogeneic Mesenchymal Stromal Cells Improve Wound Healing and Modulate the Immune Response in an Extensive Burn Model, Cell Transplant, 25, 201, 10.3727/096368915X688128

Cunha, 2017, Systemic Delivery of Bone Marrow Mesenchymal Stem Cells for In Situ Intervertebral Disc Regeneration, Stem Cells Transl Med, 6, 1029, 10.5966/sctm.2016-0033

Wang, 2017, Serum IFN-g Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients, Stem Cells Transl Med, 6, 1777, 10.1002/sctm.17-0002

Spaggiari, 2006, Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, 107, 1484, 10.1182/blood-2005-07-2775

Álvaro-Gracia, 2017, Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial, Ann Rheum Dis, 76, 196, 10.1136/annrheumdis-2015-208918

Toyserkani, 2017, Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events, Stem Cells Transl Med, 6, 1786, 10.1002/sctm.17-0031

Ciccocioppo, 2011, Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease, Gut, 60, 788, 10.1136/gut.2010.214841

Zhao, 2015, Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, J Am Soc Blood Marrow Transplant, 21, 97, 10.1016/j.bbmt.2014.09.030

Gao, 2016, Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation, J Clin Oncol Off J Am Soc Clin Oncol, 34, 2843, 10.1200/JCO.2015.65.3642

Perico, 2018, Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy, Front Immunol, 9, 1359, 10.3389/fimmu.2018.01359

Li, 2013, Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomalies, Curr Pharm Des, 19, 4893, 10.2174/13816128113199990326

Perico, 2013, Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation, Transpl Int Off J Eur Soc Organ Transplant, 26, 867, 10.1111/tri.12132

Rakha, 2014, Assessment of anti-donor T cell proliferation and cytotoxic T lymphocyte-mediated lympholysis in living donor kidney transplant patients, Methods Mol Biol Clifton NJ, 1213, 355, 10.1007/978-1-4939-1453-1_29

Augustine, 2005, Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, 5, 1971, 10.1111/j.1600-6143.2005.00958.x

Calkoen, 2014, Mesenchymal stromal cell therapy is associated with increased adenovirus-associated but not cytomegalovirus-associated mortality in children with severe acute graft-versus-host disease, Stem Cells Transl Med, 3, 899, 10.5966/sctm.2013-0191

Introna, 2014, Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 20, 375, 10.1016/j.bbmt.2013.11.033